Pleiotropic and Lipid–lowering Effects of Statins in Hypertension
Lulzim Selim Kamberi, Aurora Bedri Bakalli, Norma Muhamet Budima, Daut Rashit Gorani, Ahmet Muzaffer Karabulut, Kelmend Talat Pallaska
Mat Soc Med. 2012; 24(2): 84-86

View PDF Fulltext


Background. Data on the lowering effects of statins in hypertensive patients have been mixed and highly controversial. Some studies shows reductions effects of statins in blood pressure, whereas others do not. The evidence in the literature on the effects of statins on blood pressure raises the possibility that statins may directly lower blood pressure in addition to reduce cholesterol levels–pleiotropic effects of statins. Aim of the study. The role of statins as additional treatment in patients with severe hypertension and advanced aortic atherosclerotic plaques. Methods. We enrolled 62 patients. Study has been approved by Committee of Ethics and patients signed a Term of Free Informed Consent. All patients were studied with transoesophageal echocardiography at baseline and 12 months after enrolment. Inclusion criteria were severe hypertension and presence of aortic atherosclerotic plaques. Patients have been divided into two groups; group A (treated with antihypertenives and statins) and group B (treated, just with antihypertensives). Results. Twenty patients, of totally 38, from group A (20/38 or 52.6%) had significantly plaque reduction. One patient of totally 24 (1/24 or 4.1% ) from group B had significantly atherosclerotic plaque reduction. Difference of plaques reduction between two groups was highly significant. Regarding blood pressure levels, statins users had significantly reduction on systolic and diastolic blood pressure compared to statins nonusers. Conclusion. Hypertensive patients with presence of AA plaques treated with antihypertensives and statins have more BP reduction compared will hypertensive patients treated with antihypertensives alone.


1. Derosa G, Mugellini A, Ciccarelli L, Fogari R. Randomized, double-blind, placebo-controlled comparison of the action of orlistat, fluvastatin, or both an anthropometric measurements, blood pressure, and lipid profile in obese patients with hypercholesterolemia prescribed a standardized diet. Clin Ther. 2003; 25: 1107–1122.

2. Ferrier KE, Muhlmann MH, Baguet JP, Cameron JD, Jennings GL, Dart AM, Kingwell BA. Intensive cholesterol reduction lowers blood pressure and large artery stiffness in isolated systolic hypertension. J Am Coll Cardiol. 2002; 39: 1020–1025.

3. Goode GK, Miller JP, Heagerty AM. Hyperlipidaemia, hypertension, and coronary heart disease. Lancet. 1995; 345(8946): 362–364.

4. Wierzbicki AS. Lipid lowering: another method of reducing blood pressure? J Hum Hypertens. 2002; 16(11): 753–760.

5. Strazzullo P, Kerry SM, Barbato A, Versiero M, D’Elia L, Cappuccio FP. Do statins reduce blood pressure: a meta-analysis of randomized, controlled trials. Hypertension. 2007; 49: 792–798.

6. Leonelo EB. Blood pressure-lowering effects of statins: who benefits? Journal of Hypertension. 2009, 27: 1478–1484.

7. Rajagopalan S, Zannad F, Radauceanu A, Pitt B. A multicenter double-blind randomized controlled trial of a statin + angiotensin receptor blockade combination in patients with hypertension and concomitant hyperlipidemia. Circulation. 2004; 110(Suppl III):III–402.

8. Rajagopalan S, Zannad F, Radauceanu A, Glazer R, Jia Y, Prescott MF, Kariisa M, Pitt B. Effects of valsartan alone versus valsartan/simvastatin combination on ambulatory blood pressure, C-reactive protein, lipoproteins, and monocyte chemoattractant protein-1 in patients with hyperlipidemia and hypertension. Am J Cardiol. 2007 Jul 15; 100(2): 222-226.

9. Ikeda T, Sakurai J, Nakayama D, Takahashi Y, Matsuo K, Shibuya Y, Gomi T, Moriya H, Kobayashi S. Pravastatin has an additional depressor effect in patients undergoing long-term treatment with antihypertensive drugs. Am J Hypertens. 2004; 17: 502–506.

10. Borghi C, Prandin MG, Costa FV, Bacchelli S, Degli Esposti D, Ambrosioni E. Use of statins and blood pressure control in treated hypertensive patients with hypercholesterolemia. J Cardiovasc Pharmacol. 2000; 35: 549–555.

11. Sposito AC, Mansur AP, Coelho OR, Nicolau JC, Ramires JA. Additional reduction in blood pressure after cholesterol-lowering treatment by statins (lovastatin or pravastatin) in hypercholesterolemic patients using angiotensin-converting enzyme inhibitors (enalapril or lisinopril). Am J Cardiol. 1999; 83(1497–9): A8.

12. Koh KK, MD, Quon MJ, Han HS, Chung JW, Ahn YJ, Seo HY, Kang HM, Ahn HT, Choi SI, Shin KE. Additive Beneficial Effects of Losartan Combined With Simvastatin in the Treatment of Hypercholesterolemic, Hypertensive Patients. Circulation. 2004, Nov 29; 110: 3687-3695.

13. Kaesemeyer WH, Caldwell RB, Huang J, Caldwell RW. Pravastatin sodium activates endothelial nitric oxide synthase independent of its cholesterollowering actions. J Am Coll Cardiol. 1999 Jan; 33(1): 234-234.

14. Nickenig G, Bäumer AT, Temur Y, Kebben D, Jockenhövel F, Böhm M. Statin-sensitive dysregulated AT1 receptor function and density in hypercholesterolemic men. Circulation. 1999 Nov 23; 100(21): 2131-2134.

15. Haug C, Schmid-Kotsas A, Zorn U, Schuett S, Gross HJ, Gruenert A, Bachem MG. Endothelin-1 synthesis and endothelin B receptor expression in human coronary artery smooth muscle cells and monocyte-derived macrophages is up-regulated by low density lipoproteins. J Mol Cell Cardiol. 2001; 33: 1701-1712.

16. Wassmann S, Laufs U, Bäumer AT, Müller K, Ahlbory K, Linz W, Itter G, Rösen R, Böhm M, Nickenig G. HMG-CoA reductase inhibitors improve endothelial dysfunction in normocholesterolemic hypertension via reduced production of reactive oxygen species. Hypertension. 2001 Jun; 37(6): 1450-1457.

17. Leibovitz E, Hazanov N, Zimlichman R, Shargorodsky M, Gavish D. Treatment with atorvastatin improves small artery compliance in patients with severe hypercholesterolemia. Am J Hypertens. 2001 Nov; 14(11 Pt 1): 1096-1098.

18. Kamberi LS, Gorani DR, Çitaku HR, Selmani HH, Beqiri AI, Ardian MI. Multiplane Transesophageal Echocardiography for Multiclinical Dilemmas. Acta Inform Med. 2011; 19(3): 138-141.

19. Tomochika Y, Okuda F, Tanaka N, Wasaki Y, Tokisawa I, Aoyagi S, Morikuni C, Ono S, Okada K, Matsuzaki M. Improvement of atherosclerosis and stiffness of the thoracic descending aorta with cholesterol-lowering therapies in familiar hypercholesterolemia. Arterioscler Thromb Vasc Biol. 1996; 16: 955-962.

20. Castro DS, Angelantonio DE, Celotto A, Fiorelli M, Passaseo I, Papetti F, Caselli S, Marcantonio A, Ariel Cohen A and Natesa Pandian N. Short-term evolution (9 months) of aortic atheroma in patients with or without embolic events: a follow-up transoesophageal echocardiographic study. Eur J Echocardiogr. 2009; 10 (1): 96-102.

21. Chobanian VA, Bakris LG, Black HR, Cushman WC, Green LA, Joseph L. Izzo Jr, Jones DW, Oparil S, Wright JT, Roccella EJ. JNC 7: Complete Report Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

22. Amarenco P, Cohen A, Tzourio C, Bertrand B, Hommel M, Besson G, Chauvel C, Touboul PJ, Bousser MG. Atherosclerotic disease of the aortic arch and the risk of ischemic stroke. N Engl J Med. 1994; 331: 1474–1479.

23. Perloff D, Grim C, Flack J, et al. Human blood pressure determination by sphygmomanometry. Circulation. 1993; 88: 2460–2470.

Be the first to comment

Leave a Reply

Your email address will not be published.


Ova web-stranica koristi Akismet za zaštitu protiv spama. Saznajte kako se obrađuju podaci komentara.